fluorodeoxyglucose f18 has been researched along with Acute Promyelocytic Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bonnefoy, PB; Cornillon, J; Flandrin, P; Jacquet-Francillon, N; Prevot, N; Rigollet, L; Tavernier, E | 1 |
Cao, F; Li, J; Li, Y; Liu, X; Liu, Z; Wang, H; Wang, L; Zhao, H; Zhou, J | 1 |
1 trial(s) available for fluorodeoxyglucose f18 and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Homing of cytokine-induced killer cells during the treatment of acute promyelocytic leukemia.
Topics: Adult; Antineoplastic Agents; Brain; Cell Movement; Cell Tracking; Cytokine-Induced Killer Cells; Cytotoxicity, Immunologic; Female; Fluorodeoxyglucose F18; Humans; Immunotherapy, Adoptive; Leukemia, Promyelocytic, Acute; Liver; Lung; Male; Middle Aged; Pelvic Bones; Positron-Emission Tomography; Remission Induction; Spine; Spleen; Treatment Outcome | 2014 |
1 other study(ies) available for fluorodeoxyglucose f18 and Acute Promyelocytic Leukemia
Article | Year |
---|---|
Utility of 18F-FDG PET/CT in medical care of a promyelocytic sarcoma.
Topics: Fluorodeoxyglucose F18; Granulocyte Precursor Cells; Humans; Leukemia, Promyelocytic, Acute; Oncogene Proteins, Fusion; Positron Emission Tomography Computed Tomography; Sarcoma | 2021 |